Ibu

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ibu

Quick Facts

Property Description
Active ingredient Ibuprofen (Isobutylphenylpropanoic acid)
Form Tablet, Capsule, Oral Suspension, Topical Gel/Cream
Pharmacological class Nonsteroidal Anti-inflammatory Drug (NSAID)
Common use Pain relief, Fever reduction, Inflammation management
Origin Synthetic, derived from propionic acid

Ibuprofen: Definition, Type, and Composition

The medication Ibu is fundamentally defined by its core active ingredient, Ibuprofen, a synthetic compound derived from propionic acid. It is formally classified as a Nonsteroidal Anti-inflammatory Drug (NSAID). This classification establishes its principal actions, which are clinically recognized for managing pain and inflammation.

Its official recognition highlights its widespread utility: Ibuprofen is included on the World Health Organization's List of Essential Medicines, demonstrating its critical importance in meeting primary healthcare needs. The medicine is manufactured as a single active ingredient product and is globally available under numerous trade names that all share this same active compound.


Core Therapeutic Group and General Purpose

Ibuprofen's general purpose is to provide symptomatic relief by functioning as an analgesic (for pain), an antipyretic (for fever), and an anti-inflammatory agent (for swelling). Research confirms that NSAIDs like Ibuprofen are a well-established class of medications used to treat mild to moderate pain and reduce inflammation. This means the medicine helps to ease discomfort and control the body's reaction to irritation and elevated temperature.

Ibuprofen works by interrupting the chemical production of prostaglandins, which are responsible for triggering pain and fever signals. The substance is chemically characterized as a racemic mixture, a unique feature supported by pharmacological studies. The availability of forms like the liquid oral suspension and topical preparations ensures the medication can be administered effectively to diverse target audiences, including both adults and children.

Regulatory References

  1. WHO Essential Medicines List
  2. Ibuprofen - StatPearls - NIH

What side effects are possible with Ibu?

Possible Side Effects and Safety Information

This section summarizes the officially documented adverse reactions and safety risks of Ibu as described in authoritative government regulatory documents.

Serious Safety Risks

Regulatory agencies identify two major serious risks associated with Ibu, particularly when used long-term or at high doses:

  • Serious Gastrointestinal (GI) Risk: The medication can cause serious, sometimes fatal, GI adverse events, including bleeding, ulceration, and perforation of the stomach or intestines. These events can occur without warning symptoms.
  • Serious Cardiovascular (CV) Thrombotic Risk: Use of this medicine may increase the risk of serious CV thrombotic events, such as heart attack (myocardial infarction) and stroke. This risk may be higher with prolonged use and at the maximum daily dose of 2,400 mg or greater.

Other Documented Adverse Reactions

Adverse reactions are classified by frequency based on clinical trial data and post-marketing surveillance:

  • Common Reactions (occurring in 1 out of 100 to 1 out of 10 people) often involve the gastrointestinal system (e.g., dyspepsia, nausea, abdominal pain) and the nervous system (e.g., headache, dizziness).
  • Uncommon/Rare Reactions include hypersensitivity reactions, visual disturbances, and the potential for severe reactions such as aseptic meningitis (rarely reported).
  • Very Rare Reactions include severe, life-threatening allergic reactions (anaphylaxis) and serious skin conditions (e.g., Stevens-Johnson syndrome).

Restrictions and Special Populations

Official labeling contains specific limitations and population considerations:

  • Late Pregnancy: Use is contraindicated at 20 weeks or later in pregnancy due to the risk of fetal kidney problems and potential heart damage (premature closure of the ductus arteriosus).
  • Contraindications: The medicine must not be used following coronary artery bypass graft (CABG) surgery, or in patients with severe heart failure, active GI bleeding, or severe kidney or liver impairment.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with Ibu may result in an exaggeration of the drug's known effects, though the outcome can range from no symptoms to severe, life-threatening complications. According to official regulatory information, immediate medical attention is required for any suspected overdose.

Documented Overdose Manifestations

System Common Manifestations
Gastrointestinal Nausea, vomiting, abdominal pain
Central Nervous System (CNS) Drowsiness, dizziness, headache, confusion, seizures
Serious Outcomes Metabolic acidosis, hypotension (low blood pressure), acute kidney injury, decreased level of consciousness (coma)

Required Emergency Actions

In the event of an overdose, contact a Poison Control Center or seek emergency medical help right away. The management of an overdose is primarily symptomatic and supportive, aiming to stabilize vital signs and manage specific complications.

  • Monitoring of heart rate, breathing, and blood pressure is required.
  • Treatment may include activated charcoal to reduce absorption, and support for the airway and breathing.
  • Intravenous fluids and medicines may be administered to treat specific effects like low blood pressure or seizures.

Overdose in children who have ingested a dose greater than 400 mg/kg may require urgent medical review, even if asymptomatic.

Therapeutic Uses of Ibu

What Ibu Treats: Main Uses and Benefits

Ibuprofen is commonly used to provide symptomatic relief across a defined spectrum of discomfort, fever, and inflammation. It is applied across domains where additional symptomatic support is needed for heightened or disruptive manifestations.


Therapeutic Scope

The medication is applied in clinical settings that involve symptoms related to physical discomfort and symptoms related to inflammatory or irritative states. It is used for managing symptom clusters that may become intense or disruptive, such as discomfort linked to headaches, muscle aches, toothaches, menstrual pain, or the stiffness associated with inflammatory processes.

“Ibuprofen provides support that helps ease the overall symptom burden, particularly during acute episodes of pain or fever.”


Support Domains and Patient Benefit

This therapeutic approach is relevant when functional stability becomes affected. For instance, in contexts involving localized swelling or inflammation following minor injuries, Ibuprofen assists with maintaining functional stability and supports general well-being during symptomatic phases. It is commonly used when symptoms become temporarily overwhelming, such as the fever and body aches accompanying seasonal illnesses or during cyclical pain episodes.

Quick Fact: Support for Acute and Chronic Symptoms

Symptom Domain General Benefit Clinical Context
Pain/Fever Supports general well-being Seasonal illness, headaches
Inflammation Is relevant for easing swelling Soft tissue injury, arthritis

Eligibility and Restrictions for Use

Who Can and Cannot Use Ibuprofen (Ibu)

The eligibility for using Ibuprofen is strictly defined by regulatory guidelines, focusing on absolute contraindications and mandatory caution for specific patient populations.

Absolute Contraindications (Must Not Use)

Ibuprofen is contraindicated for patients with a known hypersensitivity to Ibuprofen or other NSAIDs, including those who have experienced asthma or allergic reactions to aspirin. Use is also prohibited for patients with severe heart failure (NYHA Class IV), severe renal or hepatic failure, and a history of active recurrent peptic ulceration or gastrointestinal bleeding.

Population Group Eligibility Status
Third Trimester Pregnancy Contraindicated
Post-CABG Surgery Pain Contraindicated
Infants under 6 months Safety and efficacy not established

Restricted and Conditional Use

The medicine should be used with caution in older adults (aged 60 and over) due to an increased risk of serious gastrointestinal events. Patients with uncontrolled hypertension or established cardiovascular disease (excluding severe heart failure) may use Ibuprofen, but high doses (2400 mg/day) are generally not recommended.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Ibuprofen's official interaction profile is characterized by the potential to amplify adverse effects when combined with certain drug classes, primarily impacting the risk of bleeding and renal function. This information is based solely on regulatory labeling.

Documented Interaction Categories

Interaction Type Interacting Substances/Classes
Increased Bleeding/GI Risk Anticoagulants (e.g., Warfarin), Antiplatelet Agents (e.g., low-dose Aspirin), Oral Corticosteroids, SSRIs/SNRIs
Altered Drug Concentrations Lithium, Methotrexate, Digoxin
Reduced Efficacy/Nephrotoxicity Antihypertensives (e.g., ACE inhibitors), Diuretics

Key Interaction Statements

  • Contraindicated Combinations: Ibuprofen must not be taken with other NSAIDs (including COX-2 inhibitors). Use is also restricted in the peri-operative setting of CABG surgery.
  • Pharmacokinetic Effect: Ibuprofen may increase the plasma levels of Lithium and high-dose Methotrexate by reducing their renal clearance, leading to potential toxicity.
  • Pharmacodynamic Effect: Co-administration with Anticoagulants or Antiplatelets heightens the risk of serious bleeding, especially in the gastrointestinal tract. This includes low-dose aspirin, where timing separation may be required to preserve the antiplatelet effect.
  • Food and Alcohol: Consumption of alcohol increases the risk of GI bleeding when taking Ibuprofen.
  • Population Considerations: The risk of certain interactions, particularly those affecting the kidneys and GI tract, is greater in elderly patients and those with existing renal or cardiac impairment.

Mechanism of Action

Non-Selective Inhibition of COX Enzymes

The mechanism of Ibuprofen is defined by its ability to interfere with key regulatory enzymes. It acts as a reversible, non-selective inhibitor of both the Cyclooxygenase-1 ( COX-1) and Cyclooxygenase-2 ( COX-2) enzymes. By occupying the active sites of these enzymes, the drug prevents them from converting arachidonic acid into prostanoids, primarily Prostaglandins ( PGE2 and PGI2), consequently reducing the generation of these signaling mediators.


Modulating Peripheral and Central Signaling

Suppression of Prostaglandin synthesis yields effects in two key physiological systems. Peripherally, the reduction of PGE2 stabilizes nociceptors (pain-sensing nerve endings), which contributes to a stabilization of the activation threshold. Centrally, the drug acts within the hypothalamus to directly inhibit PGE2 synthesis, which modulates the hypothalamic set-point for core body temperature.


Mechanistic Constraints

The non-selective nature of the inhibition means the action extends to homeostatic COX-1 activity. This includes the synthesis of prostanoids required for maintaining COX-1 dependent gastrointestinal processes.

Dosage and Administration Information

Ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID), is used to reduce fever and treat mild to moderate pain, including symptoms of arthritis and menstrual cramps. Always follow the specific instructions provided on the product label or by your healthcare provider. Using the lowest effective dose for the shortest possible duration is recommended to minimize risk of side effects.


Administration Guidelines

Factor Instruction
Dosing Interval Doses should be separated by at least 4 to 6 hours. Do not take more than the maximum daily dose listed on the product packaging, unless instructed by a physician.
With Food Ibuprofen may be taken with food or milk to help prevent stomach upset. If a faster onset of action is desired, it may be taken on an empty stomach, although this can increase the risk of gastrointestinal irritation.
Formulations Swallow tablets whole; do not chew, crush, or break them. Liquid suspensions should be shaken well before measuring, and a dedicated dosing device (syringe or measuring cup) must be used for accurate measurement.

Standard Adult Dosing for Pain/Fever (OTC)

For most over-the-counter (OTC) use, the typical dose is 200 to 400 mg taken every 4 to 6 hours. The maximum daily dose for self-treatment is generally 1200 mg within a 24-hour period.


Important Considerations

  • Children: Dosage for children must be based on weight and age; consult a healthcare professional for accurate dosing, and do not use in infants under 6 months without medical advice.
  • Other NSAIDs: Do not combine Ibuprofen with other NSAIDs (such as naproxen or aspirin for pain) as this increases the risk of serious adverse effects like gastrointestinal bleeding.
  • Duration: Do not take OTC ibuprofen for more than 10 days for pain or 3 days for fever unless directed by a doctor. Seek medical advice if symptoms worsen or do not improve.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Ibuprofen

Evidence for Use in Managing Pain from Arthritis (Rheumatoid and Osteoarthritis)

Ibuprofen was studied for physical discomfort, examining outcomes related to physical discomfort experienced by adults with Rheumatoid Arthritis and Osteoarthritis. Studies exploring this area primarily include short-term Randomized Controlled Trials (RCTs) and systematic reviews. Researchers have focused on monitoring how symptoms change over time and measuring patient-reported outcomes describing perceived discomfort, along with functional measures reflecting daily functioning or activity level.

Findings describe patterns observed in the studies where measurements of patient-reported outcomes describing perceived discomfort were compared between groups receiving Ibuprofen and those receiving an inactive substance (placebo). However, evidence is limited when considering the long-term effects of this approach. Some trials described patterns related to functional capacity metrics over the short study duration, but the overall certainty regarding long-term, sustained outcomes remains low due to the limited follow-up durations.

Evidence for Use in Mild to Moderate Acute Pain

Ibuprofen was studied for conditions associated with acute or disruptive episodes, such as headache, dental pain, and general muscle discomfort. Research in this area is extensive, drawing mainly from many acute-setting, short-course RCTs. These studies monitored outcomes describing episodic or acute changes in discomfort. Researchers specifically measured the time to change in pain scores and tracked the participants' reported use of additional pain medication.

Research highlights changes measured during the study period. For many participants, studies monitored how patient-reported outcomes describing perceived discomfort evolved in the observed populations. Studies report patterns related to measured changes in discomfort scores when compared to control groups. However, the results apply only to the specific conditions and short time frames under which they were conducted. Research does not determine whether an individual will respond similarly when managing multiple, non-acute episodes over an extended duration.

Evidence for Use in Reducing Fever (Antipyresis)

Research examined Ibuprofen in contexts involving physiological strain or stress related to elevated body temperature. Studies mainly consist of short-term RCTs that specifically monitored physiological strain or stress by tracking changes in core body temperature, often in children. Researchers measured how quickly the temperature changed and the duration over which the temperature remained changed.

Research contributes to the broader evidence landscape, reporting that body temperature measurements were observed in studies examining the time intervals after administration. Comparative studies involving other fever-reducing substances describe patterns observed in the studies regarding the duration of this measured change. This evidence base provides insight into short-term changes in temperature but does not determine the underlying mechanisms or long-term implications of temperature changes.

Long-Term Studies and Follow-Up Data

When considering conditions characterized by fluctuating or episodic manifestations, researchers have investigated outcomes spanning various time intervals. However, the majority of the current clinical research is centered on acute or short-term changes. Long-term effects are not fully established because follow-up durations were limited in most of the largest RCTs.

Data for long-term outcomes, such as durability of effect or patterns of use over many months or years, remain insufficient. This area of research highlights what is known—the short-term, acute observations—but also clearly identifies the significant gaps in understanding the long-term patterns of usage and symptom evolution.

Evidence in Specific Patient Populations

Ibuprofen was evaluated in studies focusing on children, primarily for its use in research contexts involving fluctuating or unstable symptoms related to fever. Research has been studied for its application in older adult populations, though these data often form part of smaller subgroups within broader trials. Studies examining these specific groups typically monitored outcomes related to systemic or functional imbalance relevant to the age group or comorbidity being studied.

Findings for certain groups, such as pregnant populations or those with specific organ-related comorbidities, are still emerging, or the available evidence is limited and evidence quality varies across studies. This means results apply only to the populations studied, and researchers caution against extrapolating patterns to groups where data for certain groups remain insufficient.

What Is Still Uncertain About Ibuprofen Research

Despite the large volume of research, certain limitations and uncertainties persist. Comparative evidence is lacking for some combinations of dosage and specific outcomes related to physical discomfort. Findings were mixed when evaluating the precise dose-response relationship across different outcomes related to physical discomfort.

The existing research provides context but not individual predictions, and for many conditions, the sample sizes were modest when attempting to analyze specific patient subgroups. Overall, the research landscape continues to evolve, and the data for long-term outcomes and some special populations remain areas where more research is ongoing.

Frequently Asked Questions (FAQ)

Common questions about Ibu (FAQ)

Q: What is the main difference between Ibu and acetaminophen for simple pain relief?

A: Ibu is classified as a Nonsteroidal Anti-inflammatory Drug (NSAID) and works by inhibiting COX enzymes, which may reduce inflammation, pain, and fever. Acetaminophen has a different primary mechanism and is not classified as an anti-inflammatory drug, unlike Ibuprofen. Official drug information focuses on Ibuprofen’s specific NSAID properties.

Q: How quickly does Ibu start working after taking it?

A: Regulatory labeling indicates that Ibuprofen doses should be separated by at least 4 to 6 hours, which relates to the expected duration of its effects. An exact starting time is not specified on the product label. Administration guidelines note that taking the medicine on an empty stomach may be an option, though this can increase the risk of gastrointestinal irritation.

Q: Do you have to take Ibu with food, or is it okay on an empty stomach?

A: Product information states that Ibuprofen may be taken with food or milk to help reduce the possibility of stomach upset. While taking it on an empty stomach may be an option, label information cautions that this may increase the risk of gastrointestinal irritation.

Q: Is it true that Ibu can affect blood pressure?

A: Regulatory documents indicate that Ibuprofen use requires caution for people with existing cardiovascular conditions or uncontrolled high blood pressure. Ibuprofen is known to interact with certain high blood pressure medications (antihypertensives), potentially reducing their intended effect. Official warnings focus on these interactions.

Q: Can Ibu cause stomach upset or digestive issues?

A: Official drug information indicates that gastrointestinal effects are among the common adverse reactions reported, including dyspepsia (indigestion), nausea, and abdominal pain. More seriously, the medicine carries an official warning about the potential to increase the risk of severe GI events like bleeding or ulceration, especially with prolonged use.

Q: What is the typical duration of pain relief from a standard dose of Ibu?

A: Product labeling provides the recommended minimum interval between doses. The labeling advises that doses be separated by a minimum of 4 to 6 hours. This interval is designed to align with the typical period over which the pain and fever-reducing effects are maintained.

Q: Can taking Ibu long-term cause kidney problems?

A: Ibuprofen is contraindicated (must not be used) in patients with severe kidney failure, which highlights its potential connection to renal function. Ibuprofen is known to interact with certain medications, including diuretics (water pills). Therefore, regulatory information advises caution regarding its use due to the potential impact on kidney function, particularly with extended use.

Q: Is it okay to crush or chew Ibu tablets if they are hard to swallow?

A: Administration guidelines indicate that tablets should be swallowed whole and should not be chewed, crushed, or broken. If swallowing tablets is a challenge, other official forms, such as the liquid oral suspension, may be available for administration.

Q: Are there different types or strengths of Ibu, and how do they differ?

A: Ibuprofen is available in various dosage forms, including tablets, capsules, and oral suspensions (liquids), as noted in the quick facts. Over-the-counter products are available in a range of strengths. The choice of form and strength is intended to meet diverse needs, consistent with professional guidance.

Q: Can older adults use Ibu safely, or are there special precautions?

A: Regulatory information advises that Ibuprofen use requires caution in older adults (aged 60 and over). This is due to an increased risk of serious gastrointestinal side effects in this age group. The risk of certain interactions is also noted to be greater in older populations, particularly those affecting the kidneys.

Q: Does Ibu work for muscle pain and joint inflammation?

A: Official product labeling indicates that Ibuprofen is intended for the temporary relief of minor aches and pains. This generally covers common types of discomfort, including muscular aches and the minor pain associated with arthritis or inflammation.

Q: Is Ibu considered a blood thinner, and what does that mean?

A: Ibuprofen is not formally classified as a blood thinner, but it may significantly increase the risk of bleeding in the stomach or intestines. The increased risk of bleeding is especially noted when Ibuprofen is taken alongside true blood-thinning medicines (anticoagulants) or certain antiplatelet agents like low-dose aspirin.

Q: What are the signs of an allergic reaction to Ibu?

A: The official allergy warning highlights that a severe allergic reaction to Ibuprofen is possible. Signs may include developing hives or rash, swelling of the face, experiencing wheezing (asthma attack), or going into shock. Product labeling advises discontinuing use and seeking assistance if any signs of an allergic reaction occur.

Q: Is it safe to take Ibu while taking daily aspirin?

A: Regulatory documents indicate that taking Ibuprofen while on low-dose aspirin for heart protection may decrease the benefit of the aspirin and increase the risk of serious GI events. Due to these potential effects, regulatory information advises consulting a professional regarding the timing of the two medicines.

Q: Is it normal to feel a burning sensation in the stomach after taking Ibu?

A: Official drug information lists gastrointestinal symptoms such as dyspepsia (indigestion), heartburn, and stomach pain among the common side effects of Ibuprofen. These effects are documented and are related to the medicine's mechanism of action.

Q: Why do doctors often prescribe Ibu for dental pain?

A: Official product information states that Ibuprofen is specifically indicated for the temporary relief of aches and pains, which includes toothache. It is commonly utilized for dental discomfort due to its ability to address both pain and associated inflammation (swelling).

Q: What is Ibu used for besides pain and fever?

A: Beyond its use as a pain reliever and fever reducer, Ibuprofen is also indicated for reducing inflammation and swelling. This property makes it suitable for treating inflammatory conditions like certain forms of minor arthritis pain.

Q: Why do some people experience headaches after taking Ibu?

A: Regulatory documents list headache as one of the common adverse reactions reported in clinical trials and post-marketing surveillance for Ibuprofen. While the precise cause is not always stated, it is a documented potential side effect.

Q: Is Ibu safe for people who have asthma?

A: Ibuprofen is contraindicated (must not be used) if a person has aspirin-sensitive asthma or has previously experienced a severe allergic reaction (such as wheezing or an asthma attack) after taking aspirin or any other NSAID. Use in patients with asthma requires extreme caution.

Q: How does Ibu specifically reduce inflammation in the body?

A: Ibuprofen is an anti-inflammatory agent that works by inhibiting the production of prostaglandins. These are chemical messengers produced by Cyclooxygenase (COX) enzymes that are responsible for triggering both pain and inflammation at the site of injury or illness.

Q: Does taking Ibu cause water retention or swelling?

A: Official safety warnings indicate that fluid retention and edema (swelling of the body) have been observed in some patients taking Ibuprofen. Caution is advised, especially for individuals with pre-existing conditions like heart failure or fluid retention issues.

Q: Does taking Ibu during daylight hours make your skin more sensitive to the sun?

A: Official product information notes that in rare cases, Ibuprofen has been linked to photosensitivity. This means the skin may react unusually or severely when exposed to sunlight or ultraviolet (UV) light. This possibility is noted in regulatory documents.

Q: Is it appropriate to use Ibu for tension headaches?

A: Yes, regulatory documents clearly state that Ibuprofen is indicated for the temporary relief of minor aches and pains, and this specifically includes relief from headache. It is a documented use for managing general headaches.

Q: Can Ibu interact with commonly used cold and flu medicines?

A: Official warnings state that Ibuprofen must not be taken with other medicines containing prescription or nonprescription NSAIDs. Since some cold and flu combination products may contain an NSAID, checking the ingredient list is necessary to avoid combining Ibuprofen with similar drugs.

Q: What is the primary mechanism by which Ibu blocks pain signals?

A: Ibuprofen primarily affects pain signals by reversibly inhibiting the action of Cyclooxygenase (COX) enzymes. By doing so, it stops the production of prostaglandins, which are the biological chemicals that initiate and transmit pain signals throughout the body.

How should Ibu be stored and disposed of?

How to Store and Dispose of Ibuprofen

Official regulatory guidelines define specific conditions for the storage and disposal of ibuprofen products.

Storage Requirements

Ibuprofen must be stored at room temperature, generally between 20 C and 25 C, and kept out of the reach and sight of children. To maintain stability, the medication must be protected from excessive heat, moisture, and direct light; this means storing it away from places like bathrooms and windows, and preventing it from freezing. Always keep the medicine in its original, tightly closed container until use. Dispose of the product if it has passed its expiration date or develops a strong, vinegar-like odor.

Official Disposal Protocol

The preferred method for discarding unused or expired ibuprofen is through a drug take-back program. Do not flush the medication down the toilet or pour it down the sink unless specifically instructed by the product labeling. If a take-back program is unavailable, mix the medicine with an unappealing substance (such as dirt or used coffee grounds), seal the mixture in a container, and place it in the household trash, in accordance with local requirements.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ibu found in:

A-Z Index: